Skip to Content

FDA Sends Novartis Warning Letter Over Trileptal Promotional Materials.

ROCKVILLE, Md., May 8, 2008-The FDA today posted on its website a warning letter sent to Novartis Pharmaceuticals regarding promotional materials for Trileptal. The letter and promotional materials are attached.

Posted: May 2008

Recommended for you

View comments